ABVC BioPharma, Inc. Deferred State and Local Income Tax Expense (Benefit)
ABVC BioPharma, Inc. (ABVC) reported Deferred State and Local Income Tax Expense (Benefit) of $1.60 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2023-11-15
- 2022-09-30: Deferred State and Local Income Tax Expense (Benefit) 9 month $1.60K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 9 month |
|---|---|
| 2022-09-30 | $1.60K 10-Q · filed 2023-11-15 |